Article
Pirfenidone treatment attenuates fibrosis in autosomal dominant polycystic kidney disease
2025-08-29
Abstract excerpt
<h4>ABSTRACT</h4> Autosomal dominant polycystic kidney disease (ADPKD) is a leading genetic cause of kidney failure, marked by progressive cyst expansion, inflammation and fibrosis. Renal fibrosis, characterized by myofibroblast activation and excessive extracellular matrix (ECM) deposition is a central driver of disease progression in ADPKD, yet targeted anti-fibrotic therapies remain limited. Here, we evaluated...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 53a0617b-ee98-584f-8c6f-4b571697bfcf
- DOI
- 10.1101/2025.08.25.672225
